La vendita allo scoperto per RMR Gr dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di RMR Gr. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

RMR Gr (NASDAQ:RMR) Azioni, Report sulle vendite allo scoperto

RMR Gr

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

RMR Group

The RMR Group Inc. - Class A Common Stock

The RMR Group Inc

RADISSON MINING RESOURCES by Radisson Mining Resources Inc.

Radisson Mining Resources Inc

RAND MERCHANT INVT HLDG by Rand Merchant Invt Hldgs Ltd.

OUTsurance Group Ltd

RMR INDUSTRIALS CL B by RMR Industrials, Inc.

Rocky Mountain Industrials Inc

Rimrock Gold Corp

RMRK

WIIM

Arista Networks shares are trading lower. The company reported Q3 financial results.

MNST

Monster Beverage shares are trading lower after the company reported worse-than-expected Q3 financial results.

Baird analyst Timothy Wojs maintains Tecnoglass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGLS#NYSE">TGLS</a>) with a Outperform and raises the price target from $85 to $88.

News

Price Target

Analyst Ratings

TGLS

Baird Maintains Outperform on Tecnoglass, Raises Price Target to $88

Wedbush analyst Nick Setyan reiterates Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Outperform and maintains $390 price target.

Reiteration

WING

Wedbush Reiterates Outperform on Wingstop, Maintains $390 Price Target

Baird analyst Richard Eastman maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Outperform and raises the price target from $280 to $290.

Baird Maintains Outperform on Rockwell Automation, Raises Price Target to $290

Rosenblatt analyst Steve Frankel upgrades Universal Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UEIC#NASDAQ">UEIC</a>) from Neutral to Buy and maintains the price target from $15 to $15.

Upgrades

UEIC

Rosenblatt Upgrades Universal Electronics to Buy, Maintains Price Target to $15

Baird analyst George Gianarikas maintains Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) with a Outperform and lowers the price target from $20 to $18.

RIVN

Baird Maintains Outperform on Rivian Automotive, Lowers Price Target to $18

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) with a Buy and maintains $17 price target.

VIGL

HC Wainwright & Co. Reiterates Buy on Vigil Neuroscience, Maintains $17 Price Target

The data demonstrated that the development candidate can successfully create CAR-M directly in vivo, reprogramming endogenous myeloid cells to target and destroy Glypican-3 ("GPC3"), expressing cancer cells.

CARM

MRNA

Carisma Unveils Pre-Clinical Data On Anti-GPC3 In Vivo CAR-M Therapy For Hepatocellular Carcinoma Developed In collaboration With Moderna

Guidance

Flowers Foods Narrows FY24 Net Sales Outlook From $5.091B - $5.172B To $5.116B - $5.147B (Est $5.138B),  Adjusted EPS Forecast From $1.20 - $1.30 To $1.24 - $1.28 (Est $1.25)

Baird analyst Andrew Wittmann maintains NV5 Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>) with a Neutral and lowers the price target from $26 to $25.

NVEE

Baird Maintains Neutral on NV5 Global, Lowers Price Target to $25

HC Wainwright &amp; Co. analyst Andrew Fein maintains Amylyx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) with a Buy and raises the price target from $8 to $12.

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

HC Wainwright & Co. Maintains Buy on Amylyx Pharma, Raises Price Target to $12

Trade Desk shares are trading lower despite the company reporting better-than-expected Q3 financial results.

Baird analyst Michael Halloran maintains Crane NXT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXT#NYSE">CXT</a>) with a Outperform and raises the price target from $77 to $78.

Baird Maintains Outperform on Crane NXT, Raises Price Target to $78

Barclays analyst Adrienne Yih downgrades Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Equal-Weight to Underweight and lowers the price target from $31 to $28.

Downgrades

BBWI

Barclays Downgrades Bath & Body Works to Underweight, Lowers Price Target to $28

Moderna Receives Health Canada Approval For mRESVIA RSV Vaccine for Adults Aged 60 Years and Older; Canada Is The Fourth Jurisdiction To Approve mRESVIA Following Approvals In The U.S., Europe, And Qatar

Baird analyst Andrew Wittmann maintains Bowman Consulting Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) with a Outperform and lowers the price target from $29 to $27.

BWMN

Baird Maintains Outperform on Bowman Consulting Group, Lowers Price Target to $27

By <a href="https://roboforex.com/beginners/analytics/forex-forecast/?utm_source=benzinga.com&amp;utm_medium=pr&amp;utm_campaign=rf_en_external_article_08112024&amp;utm_content=analysis&amp;utm_term=forecast" style="color:#0563c1; text-decoration:underline">RoboForex Analytical Department</a>
EUR/USD is settling around 1.0785, assessing the market impact of this week&#39;s events. With Donald Trump&rsquo;s return as US President, the market is recalibrating expectations around inflation and economic policies that his administration may reintroduce.
Trump&rsquo;s protectionist stance could stir inflationary pressures, prompting the Federal Reserve to maintain higher interest rates than anticipated. This potential for elevated rates is boosting the dollar&rsquo;s appeal.
Yesterday, the Federal Reserve cut interest rates by 25 basis points to 4.75% in line with market predictions. The Fed&rsquo;s commentary suggested no deviations from its planned rate trajectory, hinting at continued easing.
Looking ahead, another rate reduction of 25 basis points is expected at the Fed&rsquo;s December meeting, continuing its cautious but steady approach to monetary easing.
<h3>Technical analysis Of EUR/USD</h3>
<a href="https://www.benzinga.com/files/u117641/eurusdh4_72.png"><img alt="" src="https://www.benzinga.com/files/u117641/eurusdh4_72.png" style="height:280px; width:624px" /></a>
The EUR/USD pair has completed a bullish move towards 1.0820, as part of an ongoing upward impulse. Current market behaviour suggests a retracement to 1.0758 before resuming its ascent towards 1.0833. This outlook is supported by the MACD indicator, which, although below zero, is trending upwards, signalling a potential bullish continuation.
<a href="https://www.benzinga.com/files/u117641/eurusdh1_73.png"><img alt="" src="https://www.benzinga.com/files/u117641/eurusdh1_73.png" style="height:280px; width:624px" /></a>
The hourly frame shows EUR/USD undergoing a corrective phase to 1.0758. Upon reaching this level, a rebound to 1.0833 is expected, followed by another potential pullback to 1.0758. The stochastic oscillator supports this outlook, with its signal line poised to rise towards 80, suggesting increasing bullish momentum.
Disclaimer
Any forecasts contained herein are based on the author&#39;s particular opinion. This analysis may not be treated as trading advice. RoboForex bears no responsibility for trading results based on trading recommendations and reviews contained herein.
This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Eurozone

Technicals

Forex

Markets

Trading Ideas

General

EUR/USD Stabilises, Considers Trump's Impact

PAR Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAR#NYSE">PAR</a>) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. The company reported quarterly sales of $96.800 million which beat the analyst consensus estimate of $91.037 million by 6.33 percent. This is a 9.65 percent decrease over sales of $107.134 million the same period last year.

Earnings

Earnings Beats

PAR Technology Q3 2024 Adj. EPS $(0.09) Beats $(0.10) Estimate, Sales $96.800M Beat $91.037M Estimate

Biotech

Health Care

IFRX

InflaRx's Q3 Cash, Cash Equivalents And Marketable Securities Of €62M, Expected To Fund Operations Into 2026

RMR Group acquires a Denver Multifamily Property

RMR Group Non-GAAP EPS of $0.45 beats by $0.06, revenue of $205.48M misses by $24.92M

RMR Group declares $0.45 dividend

The RMR Group Inc. 2024 Q2 - Results - Earnings Call Presentation

The RMR Group Inc. (RMR) Q3 2024 Earnings Call Transcript

In a report released today, Tyler Batory from Oppenheimer maintained a Hold rating on The RMR Group (RMR – Research Report). The company's shares c...

Oppenheimer Reaffirms Their Hold Rating on The RMR Group (RMR)

An announcement from The RMR Group ( ($RMR) ) is now available. The RMR Group Inc. recently shared an investor presentation online, highlighting th...

The RMR Group Highlights Growth and Stability in Real Estate

REITs Rally As Earnings Begin

ADT Non-GAAP EPS of $0.20 beats by $0.03, revenue of $1.2B misses by $20M

AGNC

AGNCL

AGNCM

AGNCN

AGNCO

AGNCP

BLDG

BXMT

CHCT

CUBE

DHCNI

DHCNL

EQIX

FREL

GQRE

HAUS

HAUZ

HOMZ

IFGL

ILPT

INDS

INVH

IRET

KBWY

MORT

NAIL

NETL

NURE

OPINL

PFFR

PINE

PLDGP

PPTY

RDOG

REET

REGCO

REGCP

REIT

REXR

RIET

ROOF

SBAC

SBRA

SCHH

SRVR

STWD

USRT

VIOO

VRAI

WELL

XLRE

Press Releases

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Office Properties Income Trust Announces Quarterly Dividend on Common Shares

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

Seven Hills Realty Trust Announces Quarterly Dividend on Common Shares

Seven Hills Realty Trust Announces Third Quarter 2024 Results

The RMR Group Reschedules Fiscal Fourth Quarter 2024 Conference Call to Tuesday, November 12th

Comments

RMR Gr

Vendite allo scoperto

RMR Gr (NASDAQ:RMR) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO